Cardinal Health (CAH)
(Real Time Quote from BATS)
$100.99 USD
-2.40 (-2.32%)
Updated Aug 2, 2024 12:54 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CAH 100.99 -2.40(-2.32%)
Will CAH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CAH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CAH
Merit Medical (MMSI) Q2 Earnings and Revenues Beat Estimates
Cardinal Health (CAH) Rises But Trails Market: What Investors Should Know
CAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Cardinal Health (CAH) Rises As Market Takes a Dip: Key Facts
Other News for CAH
Cardinal Health: Growth Headwinds Ahead
Cardinal Health Breaks Above 200-Day Moving Average - Bullish for CAH
$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2024 on August 14
Cardinal Health price target lowered by $8 at Citi, here's why